Overview

An Exploratory Clinical Study of Dalpiciclib an&Amp;#39;d Letrozole Combined With Anlotinib Neoadjuvant Therapy in Stage II-III Postmenopausal HR+/HER2- Early Breast Cancer

Status:
NOT_YET_RECRUITING
Trial end date:
2026-08-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, open-label, exploratory clinical study
Phase:
NA
Details
Lead Sponsor:
Liu Shu
Treatments:
anlotinib
dalpiciclib